MEREO BIOPHARMA GROUP PLC
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Dec 2022 | $26.0M | $77.4M | $68.2M |
| Dec 2023 | $16.0M | $66.5M | $57.4M |
| Mar 2024 | $13.1M | $55.9M | $48.7M |
| Jun 2024 | $17.5M | $96.1M | $87.4M |
| Sep 2024 | $16.2M | $88.7M | $80.5M |
| Dec 2024 | $15.4M | $76.4M | $69.8M |
| Mar 2025 | $8.2M | $68.3M | $62.5M |
| Jun 2025 | $8.5M | $62.6M | $56.1M |
| Sep 2025 | $7.0M | $53.6M | $48.7M |
| Dec 2025 | $5.0M | $45.9M | $41.0M |
| Mar 2026 | $6.6M | $40.6M | $30.1M |
| Jun 2026 | $6.1M | $34.7M | $30.1M |